Fredun Pharmaceuticals Limited has submitted a regulatory disclosure to BSE Limited regarding the availability of the audio recording of their Earnings Conference Call for the second quarter and first half of fiscal year 2027.
The disclosure was made pursuant to Regulation 30 read with Sub para 15, Para A Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The earnings conference call was held on Monday, 16th November, 2026, and discussed the company's Un-Audited Financial Results for the quarter and half year ended on 30th September, 2026.
The audio recording of the call is available on the company's website at the following link: https://www.fredun.com/investor-meet
The document was digitally signed by Fredun Nariman Medhora, Managing Director (DIN: 01745348), on 16th November, 2026 at 14:55:02 IST.